DiabetologyNews.net

Diabetology Xagena

Xagena Mappa
Medical Meeting
Dermabase.it
Cardiobase

Search results for "Weight gain"

Exenatide ( Byetta ) reduced HbA1c with no weight gain and no increased incidence of hypoglycemia in patients with type 2 diabetes failing to achieve glycemic control with Metformin. Exenatide is t ...


Over the past few years, researchers have discovered another risk factor for developing high blood glucose and diabetes: low birth weight. In a study with mice, Joslin Diabetes Center researchers hav ...


A Phase III study showed Muraglitazar ( Pargluva ) 5 mg reduced A1C levels significantly more than Pioglitazone ( Actos ) 30 mg in patients with type 2 diabetes. Both treatment groups were taking M ...


Results from a study indicating that Exenatide ( Byetta ) injection showed sustained improvements in blood glucose control and progressive weight reduction through a year and a half of therapy for peo ...


Results from three Phase II studies showed that Sitagliptin ( Januvia ), an investigational medicine in a potentially new class of agents for the treatment for diabetes called DPP-IV ( dipeptidyl pep ...


Results from a study indicate that Exenatide injection ( Byetta ) improves blood glucose levels as effectively as Insulin Glargine ( Lantus ) for patients with type 2 diabetes failing to achieve accep ...


Researchers of the University of Utah have found why thiazolidinediones ( TZDs, glitazones ), a class of anti-diabetes drugs, cause edema. Using knockout-gene technology, researchers found that whe ...


A research suggests that children with a neuropsychiatric disease may be at risk for type 2 diabetes, and vice versa. The diseases include depression, attention-deficit hyperactivity disorder, aut ...


Researchers reported that in a two-year, controlled study people with type 2 diabetes receiving Starlix ( Nateglinide ) in combination with Metformin experienced equivalent levels of overall blood glu ...


The brain plays a major role in the ability of insulin therapy to lower blood glucose in animals with diabetes. " Our findings suggest that, in individuals with diabetes, the ability of insulin to ...


Vildagliptin ( Galvus ), a new once-daily oral treatment option for type 2 diabetes, has demonstrated efficacy, especially in patients with poor glycemic control, as well as weight loss benefits in ob ...


There is no convincing evidence that the newer class of diabetes drugs, known as glitazones or thiazolidinediones, offer real advantages over other diabetes drugs, when used on their own, concludes th ...


The treatment of patients with diabetes mellitus should be based, wherever possible, on the results of studies of substantial size and duration that measure outcomes that are meaningful to patients.Wh ...


Researchers from Louisiana State University ( LSU ) Health Sciences Center New Orleans School of Public Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development ( NICHD ...


The efficacy and safety of Lixisenatide ( Lyxumia ), a once-daily prandial glucagon-like peptide-1 ( GLP-1 ) receptor agonist, in older patients with type 2 diabetes mellitus ( T2DM ) insufficiently c ...